Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death

Philip R. Reid, M. Mirowski, Morton Maimon Mower, Edward V. Platia, Lawrence S C Griffith, Levi Watkins, Stanley M. Bach, Mir Imran, Andra Thomas

Research output: Contribution to journalArticle

Abstract

An R-wave synchronous implantable automatic cardioverter-defibrillator (IACD) was evaluated in 12 patients with repeated episodes of cardiac arrest who remained refractory to medical and surgical therapy. Seven men and 5 women, average age 61 years, surgically received a complete IACD system. Coronary artery disease was found in 11 and the prolonged Q-T syndrome in 1. The average ejection fraction was 34%, and 6 patients had severe congestive heart failure (New York Heart Association class III or IV). The IACD is a completely implantable unit consisting of 2 bipolar lead systems. One system uses a lead in the superior vena cava and on the left ventricular apex through which the cardioverting pulse is delivered. The second system employs a close bipolar lead implanted in the ventricle for sensing rate. After the onset of ventricular tachycardia or fibrillation, the IACD automatically delivers approximately 25 J. Postoperative electrophysiologic study in 10 and spontaneous ventricular tachycardia in 1 patient demonstrated appropriate IACD function and successful conversion in all with an average of 18 ± 4 seconds. The induced arrhythmias were ventricular tachycardia (160 to 300 beats/min) in 9 and ventricular fibrillation in 1. These data demonstrate that ventricular tachycardia, not ventricular fibrillation, was the predominant rhythm induced during programmed ventricular stimulation in these survivors of cardiac arrest and that the IACD effectively responded to a wide range of ventricular tachycardia rates as well as ventricular fibrillation. Use of the IACD offers an effective means of therapy for some patients who otherwise may not have survived.

Original languageEnglish (US)
Pages (from-to)1608-1613
Number of pages6
JournalThe American Journal of Cardiology
Volume51
Issue number10
DOIs
StatePublished - 1983

Fingerprint

Defibrillators
Implantable Defibrillators
Sudden Cardiac Death
Survivors
Ventricular Tachycardia
Ventricular Fibrillation
Heart Arrest
Superior Vena Cava
Pulse
Cardiac Arrhythmias
Coronary Artery Disease
Heart Failure
Therapeutics
Lead

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death. / Reid, Philip R.; Mirowski, M.; Mower, Morton Maimon; Platia, Edward V.; Griffith, Lawrence S C; Watkins, Levi; Bach, Stanley M.; Imran, Mir; Thomas, Andra.

In: The American Journal of Cardiology, Vol. 51, No. 10, 1983, p. 1608-1613.

Research output: Contribution to journalArticle

Reid, PR, Mirowski, M, Mower, MM, Platia, EV, Griffith, LSC, Watkins, L, Bach, SM, Imran, M & Thomas, A 1983, 'Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death', The American Journal of Cardiology, vol. 51, no. 10, pp. 1608-1613. https://doi.org/10.1016/0002-9149(83)90195-9
Reid, Philip R. ; Mirowski, M. ; Mower, Morton Maimon ; Platia, Edward V. ; Griffith, Lawrence S C ; Watkins, Levi ; Bach, Stanley M. ; Imran, Mir ; Thomas, Andra. / Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death. In: The American Journal of Cardiology. 1983 ; Vol. 51, No. 10. pp. 1608-1613.
@article{303a1e2e2184491597e57fb1f886b916,
title = "Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death",
abstract = "An R-wave synchronous implantable automatic cardioverter-defibrillator (IACD) was evaluated in 12 patients with repeated episodes of cardiac arrest who remained refractory to medical and surgical therapy. Seven men and 5 women, average age 61 years, surgically received a complete IACD system. Coronary artery disease was found in 11 and the prolonged Q-T syndrome in 1. The average ejection fraction was 34{\%}, and 6 patients had severe congestive heart failure (New York Heart Association class III or IV). The IACD is a completely implantable unit consisting of 2 bipolar lead systems. One system uses a lead in the superior vena cava and on the left ventricular apex through which the cardioverting pulse is delivered. The second system employs a close bipolar lead implanted in the ventricle for sensing rate. After the onset of ventricular tachycardia or fibrillation, the IACD automatically delivers approximately 25 J. Postoperative electrophysiologic study in 10 and spontaneous ventricular tachycardia in 1 patient demonstrated appropriate IACD function and successful conversion in all with an average of 18 ± 4 seconds. The induced arrhythmias were ventricular tachycardia (160 to 300 beats/min) in 9 and ventricular fibrillation in 1. These data demonstrate that ventricular tachycardia, not ventricular fibrillation, was the predominant rhythm induced during programmed ventricular stimulation in these survivors of cardiac arrest and that the IACD effectively responded to a wide range of ventricular tachycardia rates as well as ventricular fibrillation. Use of the IACD offers an effective means of therapy for some patients who otherwise may not have survived.",
author = "Reid, {Philip R.} and M. Mirowski and Mower, {Morton Maimon} and Platia, {Edward V.} and Griffith, {Lawrence S C} and Levi Watkins and Bach, {Stanley M.} and Mir Imran and Andra Thomas",
year = "1983",
doi = "10.1016/0002-9149(83)90195-9",
language = "English (US)",
volume = "51",
pages = "1608--1613",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "10",

}

TY - JOUR

T1 - Clinical evaluation of the internal automatic cardioverter-defibrillator in survivors of sudden cardiac death

AU - Reid, Philip R.

AU - Mirowski, M.

AU - Mower, Morton Maimon

AU - Platia, Edward V.

AU - Griffith, Lawrence S C

AU - Watkins, Levi

AU - Bach, Stanley M.

AU - Imran, Mir

AU - Thomas, Andra

PY - 1983

Y1 - 1983

N2 - An R-wave synchronous implantable automatic cardioverter-defibrillator (IACD) was evaluated in 12 patients with repeated episodes of cardiac arrest who remained refractory to medical and surgical therapy. Seven men and 5 women, average age 61 years, surgically received a complete IACD system. Coronary artery disease was found in 11 and the prolonged Q-T syndrome in 1. The average ejection fraction was 34%, and 6 patients had severe congestive heart failure (New York Heart Association class III or IV). The IACD is a completely implantable unit consisting of 2 bipolar lead systems. One system uses a lead in the superior vena cava and on the left ventricular apex through which the cardioverting pulse is delivered. The second system employs a close bipolar lead implanted in the ventricle for sensing rate. After the onset of ventricular tachycardia or fibrillation, the IACD automatically delivers approximately 25 J. Postoperative electrophysiologic study in 10 and spontaneous ventricular tachycardia in 1 patient demonstrated appropriate IACD function and successful conversion in all with an average of 18 ± 4 seconds. The induced arrhythmias were ventricular tachycardia (160 to 300 beats/min) in 9 and ventricular fibrillation in 1. These data demonstrate that ventricular tachycardia, not ventricular fibrillation, was the predominant rhythm induced during programmed ventricular stimulation in these survivors of cardiac arrest and that the IACD effectively responded to a wide range of ventricular tachycardia rates as well as ventricular fibrillation. Use of the IACD offers an effective means of therapy for some patients who otherwise may not have survived.

AB - An R-wave synchronous implantable automatic cardioverter-defibrillator (IACD) was evaluated in 12 patients with repeated episodes of cardiac arrest who remained refractory to medical and surgical therapy. Seven men and 5 women, average age 61 years, surgically received a complete IACD system. Coronary artery disease was found in 11 and the prolonged Q-T syndrome in 1. The average ejection fraction was 34%, and 6 patients had severe congestive heart failure (New York Heart Association class III or IV). The IACD is a completely implantable unit consisting of 2 bipolar lead systems. One system uses a lead in the superior vena cava and on the left ventricular apex through which the cardioverting pulse is delivered. The second system employs a close bipolar lead implanted in the ventricle for sensing rate. After the onset of ventricular tachycardia or fibrillation, the IACD automatically delivers approximately 25 J. Postoperative electrophysiologic study in 10 and spontaneous ventricular tachycardia in 1 patient demonstrated appropriate IACD function and successful conversion in all with an average of 18 ± 4 seconds. The induced arrhythmias were ventricular tachycardia (160 to 300 beats/min) in 9 and ventricular fibrillation in 1. These data demonstrate that ventricular tachycardia, not ventricular fibrillation, was the predominant rhythm induced during programmed ventricular stimulation in these survivors of cardiac arrest and that the IACD effectively responded to a wide range of ventricular tachycardia rates as well as ventricular fibrillation. Use of the IACD offers an effective means of therapy for some patients who otherwise may not have survived.

UR - http://www.scopus.com/inward/record.url?scp=0020630183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020630183&partnerID=8YFLogxK

U2 - 10.1016/0002-9149(83)90195-9

DO - 10.1016/0002-9149(83)90195-9

M3 - Article

C2 - 6858865

AN - SCOPUS:0020630183

VL - 51

SP - 1608

EP - 1613

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 10

ER -